Published 3 years ago

Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis

Summary by Eurek Alert

MD Anderson researchers have discovered that mutant KRAS and p53, the most frequently mutated genes in pancreatic cancer, interact to promote metastasis and tumor growth. The findings point to a new therapeutic target for this deadly cancer.

0 Articles

All

Left

Center

Right

Eurek Alert

Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis

3 years ago·Washington, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center1Last Updated3 years agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis

0 Articles

0 Articles

Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis

Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics